CRISPR Technology: Implications for the Insurance Industry and Beyond
February 28, 2020Dr. Steven J. Rigatti, consulting medical director to CRL, discusses the novel use of the CRISPR technique and its potential… Read More
Tags: CRISPR, Crispr Cas9, Dna, Life Insurance, Sickle Cell